Stem cell particles aim to heal painful Crohn's fistulas
NCT ID NCT06918808
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental treatment called DB-3Q, made from stem cell particles, for people with Crohn's disease who have painful tunnels (fistulas) near the anus. About 36 adults will receive either the treatment or a placebo to see if it safely closes the fistulas and improves MRI scans. The goal is to control the disease and heal the fistulas, not to cure Crohn's.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIANAL FISTULA DUE TO CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center/NYPH
RECRUITINGNew York, New York, 10032, United States
Contact Email: •••••@•••••
-
Direct Biologics Investigational Site
RECRUITINGAurora, Colorado, 80045, United States
-
Direct Biologics Investigational Site
RECRUITINGSt Louis, Missouri, 63130, United States
-
Direct Biologics Investigational Site
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Direct Biologics Investigational Site
RECRUITINGNashville, Tennessee, 37232, United States